lanadelumab

Monoclonal Antibodies

Products The first therapeutic monoclonal antibody was approved in 1986. Muromonab-CD3 (Orthoclone OKT3) binds to the CD3 receptor on T cells and has been used in transplantation medicine. Numerous drugs containing antibodies are now available. A selection of active substances can be found at the end of this article. These are expensive drugs. For example, … Monoclonal Antibodies

Lanadelumab

Products Lanadelumab was approved as an injectable in the US and EU in 2018 and in many countries in 2019 (Takhzyro). Structure and properties Lanadelumab is a recombinant human IgG1κ monoclonal antibody with a molecular mass of 146 kDa. It is produced by biotechnological methods. Effects The effects of lanadelumab (ATC B06AC05) are based on … Lanadelumab